[O1-3] Filovirus

[O1-3-4] Establishment of iPS-derived vascular endothelial cells to evaluate cellular damage caused by Ebola virus infection

*Murasaki Amano^1,2,3, Yasuteru Sakurai^1,3, Keiko Imamura^4,5,6, Takayuki Kondo^4,5,6, Haruhisa Inoue^4,5,6, Jiro Yasuda^1,2,3 (1. Department of Emerging Infectious Diseases, National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 2. Graduate School of Biomedical Sciences, Nagasaki University, 3. Institute of Tropical Medicine (NEKKEN), Nagasaki University, 4. Center for iPS Cell Research and Application (CiRA), Kyoto University, 5. iPSC-Based Drug Discovery and Development Team, RIKEN BioResource Research Center (BRC), 6. Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP))